USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
19 May 2022 | 02:45 PM GMT

Best routes to market for Digital Health in Oncology

Anchored by:

Francesca Wuttke
Founder & CEO
NEN HEALTH

Participants:

Francesca Wuttke Founder & CEOnen Health
Francesca Wuttke
Founder & CEOnen Health
Amanda Woodward Insights ManagerTwill
Amanda Woodward
Insights ManagerTwill
Anish Shindore Founder & Managing PartnerGSD Health
Anish Shindore
Founder & Managing PartnerGSD Health
Bruce Forsyth Sr. Fellow, Research and DevelopmentBoston Scientific
Bruce Forsyth
Sr. Fellow, Research and DevelopmentBoston Scientific
Christopher Hall Commercial Director, APACMarula Health
Christopher Hall
Commercial Director, APACMarula Health
Dave Schulte Managing DirectorMcKesson Ventures
Dave Schulte
Managing DirectorMcKesson Ventures
Jim Ternyila Product Director, Channel MarketingJohnson & Johnson
Jim Ternyila
Product Director, Channel MarketingJohnson & Johnson
Jyri Yli-Villamo Head of Pharma Global Strategic PartnershipsKaiku Health
Jyri Yli-Villamo
Head of Pharma Global Strategic PartnershipsKaiku Health
Mithun Ratnakumar Director Technology Strategy & GovernanceGerresheimer
Mithun Ratnakumar
Director Technology Strategy & GovernanceGerresheimer
Rich DeNunzio Chief Commercial OfficerClick Therapeutics
Rich DeNunzio
Chief Commercial OfficerClick Therapeutics
Scott Collins AmbassadorOrbita
Scott Collins
AmbassadorOrbita

About this Meeting

Are you working on bringing Digital Health solutions to oncology patients? What are the best routes to market to get paid? Join this session to learn from others’ experiences. 

Having the clinical evidence is not enough. Even though generating meaningful evidence is critical, identifying the best route to market, getting paid for the product and defining the right pricing model is key to building a sustainable business model in the long term. Join this peer-to-peer conversation to discuss the following: 

  • What is the best option to get paid for a digital solution in oncology? E.g D2C, pharma (as companion to their product), Saas product for hospital systems, Payers, Employers?
  • There are companies that might use only one route to market, but some of them might use different routes at the same time (e.g D2C + employers, D2C+ hospitals, etc). What do these blended commercialization models look like? How to make it work? 
  •  What are the implications of choosing one route over another? How do the evidence requirements, pricing strategies and company organization change depending on the route?